Pubblicazioni

Spinal ependymoma in adults: from molecular advances to new treatment perspectives

2023 - FRONTIERS IN ONCOLOGY

Cerretti, G.; Pessina, F.; Franceschi, E.; Barresi, V.; Salvalaggio, A.; Padovan, M.; Manara, R.; Di Nunno, V.; Bono, B. C.; Librizzi, G.; Caccese, M.; Scorsetti, M.; Maccari, M.; Minniti, G.; Navarria, P.; Lombardi, G.

Nutritional counselling for head and neck cancer patients treated with (chemo)radiation therapy: why, how, when, and what?

2023 - FRONTIERS IN ONCOLOGY

Santo, Bianca; Bertini, NiccolÃ²; Cattaneo, Carlo Guglielmo; De Matteis, Sara; De Franco, Paola; Grassi, Roberta; Iorio, Giuseppe Carlo; Longo, Silvia; Boldrini, Luca; Piras, Antonio; Desideri, Isacco; De Felice, Francesca; Salvestrini, Viola

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review

2022 - FRONTIERS IN ONCOLOGY

Rampioni Vinciguerra, Gian Luca; Sonego, Maura; Segatto, Ilenia; DallâAcqua, Alessandra; Vecchione, Andrea; Baldassarre, Gustavo; Belletti, Barbara

Chemotherapeutic risk incRNA-PVT1 SNP sensitizes metastatic colorectal cancer to FOLFOX regimen

2022 - FRONTIERS IN ONCOLOGY

Wu, S.; Yang, X.; Tang, W.; Familiari, G.; Relucenti, M.; Aschner, M.; Li, X.; Chen, R.

Editorial: Women in colorectal cancers

2022 - FRONTIERS IN ONCOLOGY

De Felice, Francesca

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review

2022 - FRONTIERS IN ONCOLOGY

Rizzo, S.; Raia, G.; Del Grande, M.; Gasparri, M. L.; Colombo, I.; Manganaro, L.; Papadia, A.; Del Grande, F.

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

2021 - FRONTIERS IN ONCOLOGY

Bonifacio, M.; Papayannidis, C.; Lussana, F.; Fracchiolla, N.; Annunziata, M.; Sica, S.; Delia, M.; Foa, R.; Pizzolo, G.; Chiaretti, S.

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients

2021 - FRONTIERS IN ONCOLOGY

Hoeh, B.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Sorce, G.; Chierigo, F.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Terrone, C.; Shariat, S. F.; Tilki, D.; Kluth, L. A.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.

Computed TomographyâBased Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis

2021 - FRONTIERS IN ONCOLOGY

Del Grande, M.; Rizzo, S.; Nicolino, G. M.; Colombo, I.; Rossi, L.; Manganaro, L.; Del Grande, F.

Relevance of pharmacogenomics and multidisciplinary management in a young-elderly patient with KRAS mutant colorectal cancer treated with first-line aflibercept-containing chemotherapy

2020 - FRONTIERS IN ONCOLOGY

Bruera, G.; DâAndrilli, A.; Simmaco, M.; Guadagni, S.; Rendina, E. A.; Ricevuto, E.

GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

2019 - FRONTIERS IN ONCOLOGY

Caraglia, M.; Correale, P.; Giannicola, R.; Staropoli, N.; Botta, C.; Pastina, P.; Nesci, A.; Caporlingua, N.; Francini, E.; Ridolfi, L.; Mini, E.; Roviello, G.; Ciliberto, D.; Agostino, R. M.; Strangio, A.; Azzarello, D.; Nardone, V.; Falzea, A.; Cappabianca, S.; Bocchetti, M.; D'Arrigo, G.; Tripepi, G.; Tassone, P.; Addeo, R.; Giordano, A.; Pirtoli, L.; Francini, G.; Tagliaferri, P.